Effect of lidocaine in thoracoscopic radical resection of lung cancer in elderly patients and its influence on postoperative recovery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060471

Enrollment

Unknown

Registered

2022-06-02

Start date

2022-05-23

Completion date

Unknown

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

experimental group:Intravenous lidocaine

control group:Normal saline

Eligibility

Sex/Gender

All

Age

65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) ?~?; 2. Aged >= 65 years; 3. BMI 18-30Kg/m^2; 4. The operation time is expected to be 2-4 hours; 5. Elderly patients undergoing radical surgery for lung cancer; 6. Well-controlled patients with hypertension and diabetes: blood pressure no higher than 150/90mmHg,HbA1c < 6.5%.

Exclusion criteria

Exclusion criteria: 1. Patients with pre-existing arrhythmia before surgery; 2. With a history of other malignant tumors, it is impossible to determine whether lung cancer is primary or not; 3. Preoperative radiotherapy, chemotherapy, hormone drugs, anti-inflammatory drugs, analgesic drugs; 4. Hepatic and renal dysfunction: serum bilirubin >20µmol/L, urea nitrogen >7.5mmol/L; 5. Mental illness, communication disorder; 6. Patients who refuse lidocaine treatment.

Design outcomes

Primary

Measure	Time frame
blood pressure;	—

Countries

China

Contacts

Public ContactGao Changjun

gaocj74@163.com+86 13379227869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026